Expression of matrix metalloproteinases in patients with uterine smooth muscle tumors: An immunohistochemical analysis of MMP-1 and MMP-2 protein expression in leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma

Journal of the Society for Gynecologic Investigation

Volumn 11, Issue 3, 2004, Pages 182-186

  Bodner Adler, B ^a,b   Bodner, K ^a   Kimberger, O ^a   Czerwenka, K ^a   Leodolter, S ^a   Mayerhofer, K ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

Author keywords

Leiomyoma; MMP 1; MMP 2 expression; Uterine leiomyosarcoma; Uterine smooth muscle tumor of uncertain malignant potential

Indexed keywords

GELATINASE A; INTERSTITIAL COLLAGENASE; PARAFFIN;

ARTICLE; CANCER INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEIOMYOMA; LEIOMYOSARCOMA; METASTASIS; MUSCLE TUMOR; MYOMETRIUM; PATIENT SELECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; STATISTICAL SIGNIFICANCE;

ADULT; AGED; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LEIOMYOMA; LEIOMYOSARCOMA; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; RETROSPECTIVE STUDIES; SMOOTH MUSCLE TUMOR; SURVIVAL RATE; UTERINE NEOPLASMS;

EID: 1642487298     PISSN: 10715576     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsgi.2003.09.004     Document Type: Article

References (18)

1. Djonov V., Cresto N., Aebersold D.M., et al. Tumor cell specific expression of MMP-2 correlates with tumor vascularisation in breast cancer. Int J Cancer. 21:(1):2002;25-30.
2. Stetler-Stevenson W.G. Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix. Am J Pathol. 148:1996;1345-1350.
3. Jones J.L., Walker R.A. Control of matrix metalloproteinase activity in cancer. J Pathol. 183:1997;377-379.
4. Kikkawa F, Nawa A, Shibata K, et al. The different stimulatory effect of normal tissues on the secretion of matrix metalloproteinases and their inhibitors of human ovarian cancer cell lines. Anticancer Res 1998;18:4323-8.
5. Brummer O., Böhmer G., Hollwitz B., Flemming P., Petry K., Kühnle H. MMP-1 and MMP-2 in the cervix uteri in different steps of malignant transformation - An immunhistochemical study. Gynecol Oncol. 84:2002;222-227.
6. Vegh G.L., Tuncer Z.S., Fulop V., Genest D.R., Mok S.C., Berkowitz R.S. Matrix metalloproteinases and their inhibitors in gestational throboblastic disease and normal placenta. Gynecol Oncol. 75:1999;248-253.
7. Zhai Y.L., Nikaido T., Toki T., Shiozwawa A., Orii A., Fijii S. Prognostic significance of bcl-2 expression in leiomyosarcoma of the uterus. Br J Cancer. 80:(10):1999;1658-1664.
8. Mittal K., Demopoulos R.I. MIB-1 (KI-67), p53, estrogen receptor, and progesterone receptor expression in uterine smooth muscle tumors. Hum Pathol. 32:(9):2001;984-987.
9. Clement P.B. The pathology of uterine smooth muscle tumors and mixed endometrial stromal smooth muscle tumors A selective review with emphasis on recent advances. Int J Gynecol Pathol. 19:2000;39-55.
10. Zaloudek C.J., Norris H.J. Mesenchymal tumors of the uterus. Kurman R.J. Blaustein's pathology of the female genital tract. 1994;849-914 Springer Verlag, New York.
11. Vollenhoven B.J., Lawrence A.S., Healy D.L. Uterine fibroids A clinical review. Br J Obstet Gynecol. 97:1990;285-298.
12. Bodner-Adler B., Bodner K., Kimberger O., Czerwenka K., Leodolter S., Mayerhofer K. MMP-1 and MMP-2 expression in uterine leiomyosarcoma and correlation with different clinico-pathologic parameters. J Soc Gynecol Investig. 10:2003;443-446.
13. Bell S.W., Kempson R.L., Hendrickson M.R. Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases. Am J Pathol. 18:(6):1994;535-558.
14. Zucker S., Lysik R.M., Zarrabi M.H., Moll U. M(r) 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer. Cancer Res. 53:1993;140-146.
15. Herbst H., Wege T., Milani S., et al. Tissue inhibitor of metallo-proteinases -1 and -2 expression in rat and human liver fibrosis. Am J Pathol. 150:1997;1647-1659.
16. Huhtala P., Chow L.T., Tryggvason K. Structure of human type IV collagenase gene. J Biol Chem. 265:1990;11077-11082.
17. Dou Q., Tarnuzzer R.W., Williams R.S., Schultz G.S., Chegini N. Differential expression of matrix metalloproteinases and their tissue inhibitors in leiomyomata A mechanism for gonadotrophin hormone agonist-induced tumor regression. Mol Hum Reprod. 3:1997;1005-1014.
18. Sozen I., Arici A. Interactions of cytocines, growth factors, and the extracellular matrix in the cellular biology of uterine leiomyomata. Fertil Steril. 78:(1):2002;1-12.